XML 45 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Shareholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of the impact of stock-based compensation expense

The Company recorded stock-based compensation expense as follows in the unaudited condensed consolidated statements of income and comprehensive income (in millions):

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

 

Stock options

 

$

0.4

 

 

$

0.4

 

 

Restricted stock units

 

 

4.2

 

 

 

3.7

 

 

Employee Stock Purchase Plan

 

 

0.2

 

 

 

0.2

 

 

Total stock-based compensation expense

 

$

4.8

 

 

$

4.3

 

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

 

Cost of product revenue

 

$

0.4

 

 

$

0.3

 

 

Selling, general and administrative

 

 

3.9

 

 

 

3.6

 

 

Research and development

 

 

0.5

 

 

 

0.4

 

 

Total stock-based compensation expense

 

$

4.8

 

 

$

4.3